Na Yang
- Topics
- Liver Disease Diagnosis and Treatment (3 papers)Pelvic floor disorders treatments (2 papers)GDF15 and Related Biomarkers (2 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEBioMed Research International
- Partner nations
- ChinaSouth Korea
In The Last Decade
Na Yang
23 papers receiving 414 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Endocrinology, Diabetes and Metabolism 161
- Molecular Biology 108
- Oncology 104
- Pharmacology 87
- Surgery 79
Countries citing papers authored by Na Yang
This map shows the geographic impact of Na Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Yang more than expected).
Fields of papers citing papers by Na Yang
This network shows the impact of papers produced by Na Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Yang. The network helps show where Na Yang may publish in the future.
Co-authorship network of co-authors of Na Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Na Yang. A scholar is included among the top collaborators of Na Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Yang. Na Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseasesbreakdown → | 175 |
| 8 | 8 | |
| 9 | 38 | |
| 10 | 8 | |
| 11 | 9 | |
| 12 | 12 | |
| 13 | 5 | |
| 14 | 2 | |
| 15 | 22 | |
| 16 | 12 | |
| 17 | 11 | |
| 18 | 59 | |
| 19 | 12 | |
| 20 | 9 |
About Na Yang
Na Yang is a scholar working on Biological Psychiatry, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 25 papers that have together received 421 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Pelvic floor disorders treatments (2 papers) and GDF15 and Related Biomarkers (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (161 citations), Pharmacology (87 citations) and Hepatology (35 citations). Na Yang has collaborated with scholars based in China and South Korea. Frequent co-authors include Wei Li, Yuxiu Li, Lingling Xu, Fan Ping, Huabing Zhang, Liyun He, Jingyue Huang, Jialu Wang, Jing Jiang and Yangyu Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.